5 Hive - 5-MeO-DMT Forum

Science and Spirituality => Science => Topic started by: moonbeam on February 22, 2021, 12:39:15 PM

Title: GH Research - private company seeking to patent a ROA
Post by: moonbeam on February 22, 2021, 12:39:15 PM

I was surprised to come across this private company doing a clinical study on the use of 5-MeO-DMT for treating treatment-resistant depression.  It looks like they’re seeking to patent a certain Route of Administration.  No mention of it being an adjunct to psychotherapy.

https://www.ghres.com/pipeline (https://www.ghres.com/pipeline)


GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress (https://www.prnewswire.co.uk/news-releases/gh-research-ltd-announces-completion-of-phase-1-clinical-study-with-gh001-5-methoxy-n-n-dimethyltryptamine-in-healthy-volunteers-and-updates-on-further-progress-843609682.html)